| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $7.73 ▲ +4.11% | Yesterday | $7.43 ▼ -0.07% | Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.43 and targets $7.73 (+4.11%). The near-term read is upside; watch $7.78 / $7.07 because daily realized volatility is about 8.94%. |
Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.43 and targets $7.73 (+4.11%). The near-term read is upside; watch $7.78 / $7.07 because daily realized volatility is about 8.94%. | ||||
| Week | $8.02 ▲ +8.01% | Last Week | $7.43 ▼ -0.07% | The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.43 to $8.02 (+8.01%). It gives upside momentum context for this stock, so breaks around $7.78 / $7.07 matter more than a single tick. |
The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.43 to $8.02 (+8.01%). It gives upside momentum context for this stock, so breaks around $7.78 / $7.07 matter more than a single tick. | ||||
| Month | $8.39 ▲ +13.00% | Last Month | $7.43 ▼ -0.07% | The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.39 (+13.00%), compared with the live reference near $7.43. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.39 (+13.00%), compared with the live reference near $7.43. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $8.91 ▲ +20.00% | Last Year | $7.43 ▼ -0.07% | The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $8.91 (+20.00%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $8.91 (+20.00%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $10.11 ▲ +36.16% | 5 Years Ago | $7.43 ▼ -0.07% | The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.11 (+36.16%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.11 (+36.16%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 99.2 | Bullish |
| MACD | 0.09 | Bullish |
| SMA 50 | $7.74 | Mid |
| SMA 200 | $7.63 | Mid |
| EMA 20 | $7.75 | Mid |
| Opening Price | $7.43 | Start Date | 2021-05-17 |
| Day Range | $6.99 – $7.86 | Market Cap | $778.49M |
| Monthly Range | $6.63 – $9.29 | 24h Volume | n/a |
| 90D Range | $6.36 – $9.59 | Circulating | n/a |
| 52W Range | $6.03 – $10.58 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.